Encouraging fair pricing, fair access, and future innovation within the US health care system | Reposts not endorsements
Loading...
ICER #WeeklyView: Covid-19 public meeting, challenges to GLP-1 access, & a rise in the number of uninsured Americans conta.cc/4vlTWV2
ICER #WeeklyView: covid-19 vaccine report, covid-19 public meeting, & narcolepsy final report conta.cc/3Q8fYvb
Institute for Clinical and Economic Review Releases Evidence Report on Vaccines for Covid-19: tinyurl.com/4t242hp7
Institute for Clinical and Economic Review Publishes Final Evidence Report on Treatment for Narcolepsy: icer.org/news-insight...
ICER #WeeklyView: ISPOR reflections, the cost of obesity Rx, & a change in the vaccine schedule conta.cc/4o8fBgF
ICER #WeeklyView: reflections on accelerated approval, a new topic, & the ISA webinar recording conta.cc/4vcowzT
Any future FDA Commissioner will have to face eroding trust in our public health institutions. Accelerated approval accounts for a minority of approvals but encapsulates trends feeding mistrust, making a good starting point to restoring FDA’s credibility.
www.healthaffairs.org/content/fore...
Couldn't attend ICER Scientific Advice (ISA) webinar? Listen to the recording here: shorturl.at/Sjzqq
Rachel Salzman, DVM, CEO of Armatus Bio, Inc., shared her experiences with the ISA program. Listen now!
Institute for Clinical and Economic Review to Assess Treatments for Friedreich’s Ataxia: icer.org/news-insight...
